An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (6)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (0)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (1)
  • (-) Breast (5)
  • Gastro-intestinal (12)
  • Genito-urinary (2)
  • Gynecological (0)
  • Head and neck (6)
  • (-) Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (1)
  • Pediatric (4)
  • Reirradiation (2)
  • Sarcomas (3)
  • Thoracic (5)
  • Reset filters
  • (-) Dosimetry
  • (-) Breast
  • (-) Hodgkin and Non-Hodgkin lymphoma

Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma

08/08/2021
/ Publications
/
Dosimetry
IMRT

A health-economic study by the Jacksonville group. This study utilized (1) patient-level dosimetric information for a cost-effectiveness analysis using a Markov...

Proton Therapy for Primary Breast Cancer.

08/06/2018
/ Publications
/
Dosimetry
Clinical Trial

A review by Hug EB on PT for breast cancer. The author stated that in a small but significant percentage of patients requiring adjuvant radiotherapy for left...

Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer.

04/04/2018
/ Publications
/
Dosimetry
Chemotherapy

A systematic review by MSKCC about the increasing emphasis on the mitigation of iatrogenic morbidity, with particular attention to heart and lung exposure in...

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

16/05/2021
/ Publications
/
Dosimetry
Reirradiation
Toxicity

A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.

16/03/2023
/ Publications
/
Dosimetry
Hypofractionation
Toxicity

Fifty patients were treated with PT using two different regimens following lumpectomy. 14 patients received IMPT to a total dose of 50 Gy in 25 fractions...

Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy.

16/10/2023
/ Publications
/
Dosimetry
Toxicity

The active and inactive (pro-BNP and NT-proBNP) forms of BNP are classically used as biomarkers for diagnosing and monitoring acute and chronic heart failure...

Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies